1. Home
  2. HALO vs DRS Comparison

HALO vs DRS Comparison

Compare HALO & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • DRS
  • Stock Information
  • Founded
  • HALO 1998
  • DRS 1969
  • Country
  • HALO United States
  • DRS United States
  • Employees
  • HALO N/A
  • DRS N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • DRS Military/Government/Technical
  • Sector
  • HALO Health Care
  • DRS Industrials
  • Exchange
  • HALO Nasdaq
  • DRS Nasdaq
  • Market Cap
  • HALO 7.6B
  • DRS 11.0B
  • IPO Year
  • HALO N/A
  • DRS N/A
  • Fundamental
  • Price
  • HALO $76.33
  • DRS $42.02
  • Analyst Decision
  • HALO Buy
  • DRS Strong Buy
  • Analyst Count
  • HALO 8
  • DRS 7
  • Target Price
  • HALO $70.25
  • DRS $46.43
  • AVG Volume (30 Days)
  • HALO 1.9M
  • DRS 864.9K
  • Earning Date
  • HALO 10-30-2025
  • DRS 10-29-2025
  • Dividend Yield
  • HALO N/A
  • DRS 0.86%
  • EPS Growth
  • HALO 68.93
  • DRS 32.60
  • EPS
  • HALO 4.37
  • DRS 0.94
  • Revenue
  • HALO $1,178,672,000.00
  • DRS $3,421,000,000.00
  • Revenue This Year
  • HALO $32.57
  • DRS $11.94
  • Revenue Next Year
  • HALO $23.25
  • DRS $6.63
  • P/E Ratio
  • HALO $17.49
  • DRS $44.83
  • Revenue Growth
  • HALO 34.97
  • DRS 11.43
  • 52 Week Low
  • HALO $42.01
  • DRS $26.75
  • 52 Week High
  • HALO $77.60
  • DRS $49.31
  • Technical
  • Relative Strength Index (RSI)
  • HALO 73.95
  • DRS 50.27
  • Support Level
  • HALO $74.52
  • DRS $40.32
  • Resistance Level
  • HALO $77.60
  • DRS $42.44
  • Average True Range (ATR)
  • HALO 1.67
  • DRS 0.99
  • MACD
  • HALO -0.15
  • DRS 0.19
  • Stochastic Oscillator
  • HALO 79.18
  • DRS 66.73

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

Share on Social Networks: